Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-02

Clinical Trial Update: Riluzole to Treat Depression in Bipolar Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial of riluzole for bipolar disorder was terminated; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Riluzole (riluzole)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Bipolar Disorder | Phase 2 | Status: TERMINATED | Results posted: 2016-05-02